MeSH Review:
Leukemia, B-Cell, Chronic
- Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Wang, Z.G., Rivi, R., Delva, L., König, A., Scheinberg, D.A., Gambacorti-Passerini, C., Gabrilove, J.L., Warrell, R.P., Pandolfi, P.P. Blood (1998)
- Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells. Shimamura, R., Kudo, J., Kondo, H., Dohmen, K., Gondo, H., Okamura, S., Ishibashi, H., Niho, Y. Blood (1990)
- Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells. Huang, M.R., Olsson, M., Kallin, A., Pettersson, U., Tötterman, T.H. Gene Ther. (1997)
- Combination therapy with nucleoside analogs and alkylating agents. Johnston, J.B., Verburg, L., Shore, T., Williams, M., Israels, L.G., Begleiter, A. Leukemia (1994)
- Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies. Marinov, J., Koubek, K., Starý, J. Neoplasma (1993)
- Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells. Long, B.W., Witte, P.L., Abraham, G.N., Gregory, S.A., Plate, J.M. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells. Runarsson, G., Liu, A., Mahshid, Y., Feltenmark, S., Pettersson, A., Klein, E., Björkholm, M., Claesson, H.E. Blood (2005)
- P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Adinolfi, E., Melchiorri, L., Falzoni, S., Chiozzi, P., Morelli, A., Tieghi, A., Cuneo, A., Castoldi, G., Di Virgilio, F., Baricordi, O.R. Blood (2002)
- Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. König, A., Wrazel, L., Warrell, R.P., Rivi, R., Pandolfi, P.P., Jakubowski, A., Gabrilove, J.L. Blood (1997)
- p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Döhner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S. Blood (1995)
- Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells. Biswal, S.S., Datta, K., Acquaah-Mensah, G.K., Kehrer, J.P. Toxicology (2000)
- L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia. Böhme, A., Wolter, M., Hoelzer, D. Ann. Hematol. (1998)
- Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Billard, C., Izard, J.C., Roman, V., Kern, C., Mathiot, C., Mentz, F., Kolb, J.P. Leuk. Lymphoma (2002)
- XbaI RFLP of ETS-1 oncogene in chronic B-cell leukaemia. Crossen, P.E., Morrison, M.J. Leukemia (1992)
- Does IL-2 receptor expression and secretion in chronic B-cell leukemia have a role in down-regulation of the immune system? Burton, J., Kay, N.E. Leukemia (1994)
- Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias. Döhner, H., Pilz, T., Fischer, K., Cabot, G., Diehl, D., Fink, T., Stilgenbauer, S., Bentz, M., Lichter, P. Leuk. Lymphoma (1994)
- The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Kitabayashi, A., Hirokawa, M., Miura, A.B. Int. J. Hematol. (1995)
- Flow cytometry of TPA-induced changes in cells of chronic B-cell leukemias. Munker, R., Ellwart, J., Ziegler-Heitbrock, H.W. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. (1987)
- Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5- chronic B-cell leukemia. Ikematsu, W., Ikematsu, H., Okamura, S., Otsuka, T., Harada, M., Niho, Y. Blood (1994)
- Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Bauvois, B., Dumont, J., Mathiot, C., Kolb, J.P. Leukemia (2002)
- Heterogeneity in terms of interleukin 4-dependent regulation of Fc epsilon...receptor/CD23 expression on chronic B-lymphocytic leukemia cells. Ishida, H., Kumagai, S., Iwai, K., Takahashi, T., Kawabe, T., Yodoi, J., Arai, N., Namiuchi, S., Konaka, Y., Imura, H. Immunol. Lett. (1989)
- Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor. Shiiba, M., Takaki, S., Takatsu, K. Int. Arch. Allergy Immunol. (1996)
- Lack of 5' BCL2 rearrangements in B-cell leukemia. Crossen, P.E., Morrison, M.J. Cancer Genet. Cytogenet. (1993)